公开(公告)号：US12115220B2

公开(公告)日：2024-10-15

申请号：US17309186

申请日：2019-11-05

Applicant: Inspired Material Solutions, LLC

Inventor： Mark A. Latta

IPC: A61K36/00 ,  A61K9/00 ,  A61K31/02 ,  A61K31/045 ,  A61K31/047 ,  A61K31/085 ,  A61K31/14 ,  A61K31/155 ,  A61K31/167 ,  A61K31/221 ,  A61K31/245 ,  A61K31/4164 ,  A61K31/4178 ,  A61K31/4425 ,  A61K31/7036 ,  A61K31/714 ,  A61K31/717 ,  A61K33/00 ,  A61K33/06 ,  A61K33/16 ,  A61K33/30 ,  A61K33/40 ,  A61K33/42 ,  A61K35/644 ,  A61K36/185 ,  A61K36/28 ,  A61K36/484 ,  A61K36/537 ,  A61K36/889 ,  A61K38/12 ,  A61K47/34

CPC classification number: A61K47/34 ,  A61K9/006 ,  A61K31/02 ,  A61K31/045 ,  A61K31/047 ,  A61K31/085 ,  A61K31/14 ,  A61K31/155 ,  A61K31/167 ,  A61K31/221 ,  A61K31/245 ,  A61K31/4164 ,  A61K31/4178 ,  A61K31/4425 ,  A61K31/7036 ,  A61K31/714 ,  A61K31/717 ,  A61K33/00 ,  A61K33/06 ,  A61K33/16 ,  A61K33/30 ,  A61K33/40 ,  A61K33/42 ,  A61K35/644 ,  A61K36/185 ,  A61K36/28 ,  A61K36/484 ,  A61K36/537 ,  A61K36/889 ,  A61K38/12

Abstract: An oral mucosal carrier comprising a combination of two different viscosity dimethicone components, wherein the difference between the two different viscosity dimethicone components is about 2.0 million cP or greater; and comprising at least one active agent.

公开(公告)号：US20240226050A9

公开(公告)日：2024-07-11

申请号：US18400883

申请日：2023-12-29

Applicant: Nuseed Nutritional US Inc.

Inventor： Stuart Littler

IPC: A61K31/202 ,  A61K31/232 ,  A61K36/185 ,  A61K36/28 ,  A61K36/286 ,  A61K36/31 ,  A61K36/48 ,  A61K36/55 ,  A61K36/81 ,  A61K36/889 ,  A61K36/899

CPC classification number: A61K31/202 ,  A61K31/232 ,  A61K36/185 ,  A61K36/28 ,  A61K36/286 ,  A61K36/31 ,  A61K36/48 ,  A61K36/55 ,  A61K36/81 ,  A61K36/889 ,  A61K36/899 ,  A61K2236/13 ,  A61K2236/53

Abstract: There is provided a vegetable-based lipid composition comprising very high levels of DHA, together with at least one other long-chain polyunsaturated fatty acid (typically as fatty acid esters). The composition typically contains low levels of EPA and palmitic acid. The composition is obtainable from a single source by conventional processing methods, and has improved stability properties.

公开(公告)号：US12005098B2

公开(公告)日：2024-06-11

申请号：US16461977

申请日：2017-11-23

Applicant: PEPSIS LIMITED

Inventor： John Hunter ,  Rosemary Waring

IPC: C12Q1/40 ,  A23K10/30 ,  A23K10/38 ,  A23K20/158 ,  A23K20/189 ,  A23K20/20 ,  A23K20/24 ,  A23K50/20 ,  A61K9/14 ,  A61K31/122 ,  A61K31/19 ,  A61K31/198 ,  A61K31/20 ,  A61K31/351 ,  A61K31/352 ,  A61K31/366 ,  A61K31/7008 ,  A61K33/06 ,  A61K33/24 ,  A61K36/185 ,  A61K36/45 ,  A61K36/889 ,  A61K38/47 ,  A61K45/06 ,  C12Q1/34

CPC classification number: A61K38/47 ,  A23K10/30 ,  A23K10/38 ,  A23K20/158 ,  A23K20/189 ,  A23K20/24 ,  A23K20/30 ,  A23K50/20 ,  A61K9/14 ,  A61K31/122 ,  A61K31/19 ,  A61K31/198 ,  A61K31/20 ,  A61K31/351 ,  A61K31/352 ,  A61K31/366 ,  A61K31/7008 ,  A61K33/06 ,  A61K33/24 ,  A61K36/185 ,  A61K36/45 ,  A61K36/889 ,  A61K45/06 ,  C12Q1/34 ,  C12Q1/40 ,  C12Y302/01001 ,  C12Y302/01002 ,  C12Y302/0108 ,  A23V2250/00 ,  A23V2250/1578 ,  A23V2250/1586 ,  A23V2250/1612 ,  A23V2250/1878 ,  A23V2250/21 ,  Y02P60/87 ,  A61K33/06 ,  A61K2300/00 ,  A61K33/24 ,  A61K2300/00 ,  A61K31/352 ,  A61K2300/00 ,  A61K31/198 ,  A61K2300/00 ,  A61K31/7008 ,  A61K2300/00 ,  A61K31/122 ,  A61K2300/00 ,  A61K36/185 ,  A61K2300/00 ,  A61K36/45 ,  A61K2300/00

Abstract: The present invention relates to compositions comprising: malt extract including a plurality of enzymatically active enzymes including at least fructanase and amylase; one or more medium-chain triglycerides (MCTs) and/or at least one biologically acceptable metal component and use of those compositions as veterinary and human medicaments.

公开(公告)号：US20240164410A1

公开(公告)日：2024-05-23

申请号：US18552070

申请日：2022-03-25

Applicant: BrainLuxury Inc.

Inventor： Axel Bouchon ,  Herman Schützinger

IPC: A23L2/06 ,  A23L2/52 ,  A61K9/00 ,  A61K9/107 ,  A61K31/05 ,  A61K31/198 ,  A61K31/201 ,  A61K31/355 ,  A61K31/375 ,  A61K31/381 ,  A61K31/405 ,  A61K31/593 ,  A61K33/06 ,  A61K36/02 ,  A61K36/55 ,  A61K36/889 ,  A61P25/26

CPC classification number: A23L2/06 ,  A23L2/52 ,  A61K9/0095 ,  A61K9/107 ,  A61K31/05 ,  A61K31/198 ,  A61K31/201 ,  A61K31/355 ,  A61K31/375 ,  A61K31/381 ,  A61K31/405 ,  A61K31/593 ,  A61K33/06 ,  A61K36/02 ,  A61K36/55 ,  A61K36/889 ,  A61P25/26

Abstract: The disclosure is in part directed to shelf-stable, emulsion-forming liquid compositions, liquid beverage compositions, and fatty acid vesicle-forming liquid compositions for increased neurosystem uptake of amino acids present in the compositions when consumed by a subject.

公开(公告)号：US20240156717A1

公开(公告)日：2024-05-16

申请号：US18503688

申请日：2023-11-07

Applicant: KYUNGPOOK NATIONAL UNIVERSITY INDUSTRY - ACADEMIC COOPERATION FOUNDATION

Inventor： Sang Han Lee

IPC: A61K8/9794 ,  A61K36/889 ,  A61P17/00 ,  A61Q19/02

CPC classification number: A61K8/9794 ,  A61K36/889 ,  A61P17/00 ,  A61Q19/02

Abstract: The present disclosure relates to a composition for skin whitening containing a Nypa fruticans extract as an active ingredient. The composition has an effect of reducing melanin content and inhibiting melanogenesis, and enhances a skin whitening effect by enhancing autophagy activity, and thus can be used in a cosmetic composition, a health functional food composition, and a pharmaceutical composition.

公开(公告)号：US20240139273A1

公开(公告)日：2024-05-02

申请号：US18450460

申请日：2023-08-16

Applicant: Changde Jizhi Biological Technology Co., Ltd

Inventor： Xinqiao HE

IPC: A61K36/889 ,  A61K45/06

CPC classification number: A61K36/889 ,  A61K45/06

Abstract: An areca nut product and preparation method thereof, and an areca nut additive agent are provided. The areca nut product is prepared from areca nuts, citric acid, mature vinegar, chitosan, active zinc oxide, monazite calcined distilled water, bovine bone protein peptide, lipase, isomaltooligosaccharide, soybean lecithin, ginseng, atractylodes macrocephala, poria cocos, liquorice, astragalus, notoginseng, tangerine peel, folium eucommiae, citronella grass, and mucor. Experimental tests shows that the areca nut product of the disclosure has a good antiviral effect, and the areca nut product has good preventive and therapeutic effects on oral diseases; compared with ordinary areca nut products, carcinogenic study has shown that carcinogenicity of the areca nut product of the disclosure has significantly reduced.

公开(公告)号：US11969411B2

公开(公告)日：2024-04-30

申请号：US17341312

申请日：2021-06-07

Applicant: AXCESS GLOBAL SCIENCES, LLC

Inventor： Ryan Lowery ,  Jacob Wilson ,  Terry LaCore

IPC: A61K31/4355 ,  A61K9/107 ,  A61K31/00 ,  A61K31/19 ,  A61K31/4745 ,  A61K36/889 ,  A61K45/06 ,  A61K47/44 ,  A61K47/69 ,  A61P3/08 ,  A61K9/00

CPC classification number: A61K31/4355 ,  A61K9/1075 ,  A61K31/00 ,  A61K31/19 ,  A61K31/4745 ,  A61K36/889 ,  A61K45/06 ,  A61K47/44 ,  A61K47/6911 ,  A61P3/08 ,  A61K9/0053

Abstract: In various implementations, berberine metabolites, such as dihydroberberine and/or tetrahydroberberine, may be administered to manage blood glucose levels, increase ketone levels (e.g., blood concentration of ketones), and/or for therapeutic purposes in humans. The administration of a pharmaceutically effective amount of berberine metabolites, such as dihydroberberine, may reduce fasting blood glucose levels, improve glucose tolerance, and/or improve blood ketone response. In some implementations, berberine metabolites may be administered with one or more other compounds.

公开(公告)号：US20240130993A1

公开(公告)日：2024-04-25

申请号：US18400883

申请日：2023-12-29

Applicant: Nuseed Nutritional US Inc.

Inventor： Stuart Littler

IPC: A61K31/202 ,  A61K31/232 ,  A61K36/185 ,  A61K36/28 ,  A61K36/286 ,  A61K36/31 ,  A61K36/48 ,  A61K36/55 ,  A61K36/81 ,  A61K36/889 ,  A61K36/899

CPC classification number: A61K31/202 ,  A61K31/232 ,  A61K36/185 ,  A61K36/28 ,  A61K36/286 ,  A61K36/31 ,  A61K36/48 ,  A61K36/55 ,  A61K36/81 ,  A61K36/889 ,  A61K36/899 ,  A61K2236/13 ,  A61K2236/53

Abstract: There is provided a vegetable-based lipid composition comprising very high levels of DHA, together with at least one other long-chain polyunsaturated fatty acid (typically as fatty acid esters). The composition typically contains low levels of EPA and palmitic acid. The composition is obtainable from a single source by conventional processing methods, and has improved stability properties.

公开(公告)号：US11957726B2

公开(公告)日：2024-04-16

申请号：US16645679

申请日：2017-09-08

Applicant: BEIJING HEBABIZ BIOTECHNOLOGY CO., Inc.

Inventor： James Zhou

IPC: A61K36/815 ,  A61K31/155 ,  A61K31/7048 ,  A61K36/889 ,  A61K36/8945 ,  A61P3/10

CPC classification number: A61K36/815 ,  A61K31/155 ,  A61K31/7048 ,  A61K36/889 ,  A61K36/8945 ,  A61P3/10 ,  A61K2236/331

Abstract: A pharmaceutical composition or a health food composition for controlling blood sugar, raw materials of which include dioscoreae rhizome, medlar, and coconut oil. A preparation method for the composition includes: mixing dioscoreae rhizome and a decoction thereof with medlar for homogenization, pulverization and drying, and mixing the resultant product with coconut oil and water, followed by baking and drying. Further disclosed are a pharmaceutical preparation or a health food including the composition and an excipient, and a use of the composition in the preparation of a pharmaceutical preparation or a health food for reducing or eliminating diabetic conditions.

公开(公告)号：US20240024403A1

公开(公告)日：2024-01-25

申请号：US18197213

申请日：2023-05-15

Applicant: Unigen, Inc.

Inventor： Lidia Alfaro Brownell ,  Byong-II Choi ,  Brandon Corneliusen ,  Mei-Feng Hong ,  Eu-Jin Hyun ,  QI Jia ,  Ping Jiao ,  Hyun-Jin Kim ,  Mi-Ran Kim ,  Tae-Woo Kim ,  Bo-Su Lee ,  Young-Chul Lee ,  Jeong-Bum Nam ,  Mesfin Yimam ,  Ji-Hye Hwang ,  Mi-Sun Oh

IPC: A61K36/575 ,  A61K36/37 ,  A61K36/53 ,  A61K36/185 ,  A61K36/752 ,  A61K36/889 ,  A61K36/10 ,  A61K36/258 ,  A61K36/346 ,  A61K36/38 ,  A61K36/56 ,  A61K36/605 ,  A61K36/67 ,  A61K31/352 ,  A61K45/06 ,  A61K31/12 ,  A61K31/343

CPC classification number: A61K36/575 ,  A61K36/37 ,  A61K36/53 ,  A61K36/185 ,  A61K36/752 ,  A61K36/889 ,  A61K36/10 ,  A61K36/258 ,  A61K36/346 ,  A61K36/38 ,  A61K36/56 ,  A61K36/605 ,  A61K36/67 ,  A61K31/352 ,  A61K45/06 ,  A61K31/12 ,  A61K31/343

Abstract: The present disclosure provides Diels-Alder adducts of chalcone and prenylphenyl moieties capable of modulating the activity of cannabinoid receptors, and to oligomers of flavan-3-ol capable of modulating fat absorption and storage. Such Diels-Alder adducts of chalcone and prenylphenyl moieties or oligomers of flavan-3-ol can optionally be used in combination with other weight management agents, such as anorectic agents, a lipase inhibitors, other cannabinoid receptor modulators, psychotropic agents, insulin sensitizers, stimulants, or satiety agents, as well as to methods of use thereof such as treating or preventing weight gain or obesity, promoting weight loss, appetite suppression, modifying satiety, or the like.